HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites wiki
 


Eli Lilly and Company Company News

Wed, 01 May 2019 11:29:00 GMT
Eli Lilly misses on revenue in face of pricing pressures and growing generic competition - MarketWatch
<ol><li> Eli Lilly misses on revenue in face of pricing pressures and growing generic competition MarketWatch</font></li><li><a href="/url/?u=https://finance.yahoo.com/news/eli-lilly-quarterly-profit-more-104131429.html" target="_blank">Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip Yahoo Finance</font></li><li><a href="/url/?u=https://www.cnbc.com/2019/04/30/3-major-pharma-companies-just-reported-earning-heres-how-they-did.html" target="_blank">Three major pharmaceutical companies just reported earnings — here's how they did CNBC</font></li><li><a href="/url/?u=https://www.bloomberg.com/opinion/articles/2019-04-30/pfizer-pfe-eli-lilly-lly-put-price-squeeze-on-themselves" target="_blank">Big Pharma Puts the Price Squeeze on Itself Bloomberg</font></li><li><a href="/url/?u=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-and-company-nyselly-delivered-a-better-roe-than-its-industry/" target="_blank">Eli Lilly and Company (NYSE:LLY) Delivered A Better ROE Than Its Industry Simply Wall St</font></li><li><strong><a href="/url/?u=https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWpqeDdYdmpZQU1FZjlPQkxONnRIb2RLQUFQAQ?oc=5" target="_blank">View full coverage on Google News</a></strong></li></ol>
Tue, 30 Apr 2019 07:00:00 GMT
Eli Lilly and Company 2019 Q1 - Results - Earnings Call Slides - Seeking Alpha
Eli Lilly and Company 2019 Q1 - Results - Earnings Call Slides Seeking Alpha The following slide deck was published by Eli Lilly and Company in conjunction with their 2019 Q1 earnings call.
Mon, 29 Apr 2019 07:00:00 GMT
Insulin-maker Eli Lilly is scheduled to report earnings Tuesday. Here’s what to expect - MarketWatch
Insulin-maker Eli Lilly is scheduled to report earnings Tuesday. Here’s what to expect MarketWatch Pharmaceutical giant Eli Lilly is scheduled to report earnings on Tuesday ahead of the market open, and analysts are bullish on the stock.
Wed, 08 May 2019 19:40:43 GMT
Ride Out The Next Market Storm With Eli Lilly and Company (LLY), Immunomedics, Inc. (IMMU) - Financial Mercury
Ride Out The Next Market Storm With Eli Lilly and Company (LLY), Immunomedics, Inc. (IMMU) Financial Mercury The shares of Eli Lilly and Company (NYSE:LLY) has been pegged with a rating of Buy by Edward Jones in its latest research note that was published on April ...
Thu, 09 May 2019 21:10:00 GMT
At First Glance, Such A Possibility Seems Ridiculous: Monster Beverage Corporation (MNST), Eli Lilly and Company (LLY) - Post Analyst
At First Glance, Such A Possibility Seems Ridiculous: Monster Beverage Corporation (MNST), Eli Lilly and Company (LLY) Post Analyst Monster Beverage Corporation (NASDAQ:MNST) recently ticked higher on weak volume. About 3210429 contracts were traded on 08-May-19 compared to daily ...
Wed, 17 Apr 2019 07:00:00 GMT
Eli Lilly and Company (NYSE:LLY): What Are The Future Prospects? - Simply Wall St
Eli Lilly and Company (NYSE:LLY): What Are The Future Prospects? Simply Wall St Since Eli Lilly and Company (NYSE:LLY) released its earnings in December 2018, the consensus outlook from analysts appear fairly confident, with profits ...
Thu, 09 May 2019 11:10:00 GMT
Market price of Eli Lilly and Company (LLY) share is reasonable or not? - Wall Street Morning
Market price of Eli Lilly and Company (LLY) share is reasonable or not? Wall Street Morning Eli Lilly and Company (LLY) in a recent session, the traded price of the stock is Upswing on trade volume of 2.99 million. 116.25 USD is the clocking price of the ...
Thu, 25 Apr 2019 07:00:00 GMT
Eli Lilly Receives Positive Data For Hard-To-Detect Inflammatory Arthritis - Seeking Alpha
Eli Lilly Receives Positive Data For Hard-To-Detect Inflammatory Arthritis Seeking Alpha Eli Lilly announced positive results for its late-stage study using Taltz to treat patients with Non-radiographic axial spondyloarthritis. The phase 3 study, kn.
Mon, 22 Apr 2019 07:00:00 GMT
Lilly and Avidity Biosciences Announce Licensing and Research Collaboration - PRNewswire
Lilly and Avidity Biosciences Announce Licensing and Research Collaboration PRNewswire INDIANAPOLIS and LA JOLLA, Calif., April 22, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Avidity Biosciences, Inc. today announced a ...
Mon, 22 Apr 2019 07:00:00 GMT
Eli Lilly stock down 3.4% despite positive Phase 3 findings for Taltz - MarketWatch
Eli Lilly stock down 3.4% despite positive Phase 3 findings for Taltz MarketWatch Shares of Eli Lilly and Co. were down 3.4% in premarket trade Monday despite the company's announcement that a Phase 3 study of its drug Taltz had met both.